M
Margherita Massa
Researcher at University of Pavia
Publications - 103
Citations - 4455
Margherita Massa is an academic researcher from University of Pavia. The author has contributed to research in topics: Myelofibrosis & Progenitor cell. The author has an hindex of 31, co-authored 97 publications receiving 4124 citations. Previous affiliations of Margherita Massa include University of Brescia.
Papers
More filters
Journal ArticleDOI
Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction
Margherita Massa,Vittorio Rosti,Maurizio Ferrario,Rita Campanelli,Isabella Ramajoli,R. Rosso,Gaetano M. De Ferrari,Marco Ferlini,Lucio Goffredo,Alessandra Bertoletti,Catherine Klersy,Alessandro Pecci,Remigio Moratti,Luigi Tavazzi +13 more
TL;DR: Spontaneous mobilization of both HPCs and EPCs occurs within a few hours from the onset of AMI and is detectable until 2 months, while the number of endothelial colonies was higher in patients with AMI (T0) than in CTRLs (P < .05).
Journal ArticleDOI
Correlation of Serum Interleukin-6 Levels with Joint Involvement and Thrombocytosis in Systemic Juvenile Rheumatoid Arthritis
Fabrizio De Benedetti,Margherita Massa,Piera Robbioni,Angelo Ravelli,Giuseppe Roberto Burgio,Alberto Martini +5 more
TL;DR: Serum IL-6 levels correlated with the extent and severity of joint involvement, and with platelet counts, suggest that IL- 6 plays a significant role in the pathogenesis of systemic-onset JRA.
Journal ArticleDOI
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.
Giovanni Barosi,Gaetano Bergamaschi,Monia Marchetti,Alessandro M. Vannucchi,Paola Guglielmelli,Elisabetta Antonioli,Margherita Massa,Vittorio Rosti,Rita Campanelli,Laura Villani,Gianluca Viarengo,Elisabetta Gattoni,Giancarla Gerli,Giorgina Specchia,Carmine Tinelli,Alessandro Rambaldi,Tiziano Barbui +16 more
TL;DR: The JAK2 V617F genotype should be considered in any future risk stratification of patients with PMF and independently predicted the evolution toward large splenomegaly, need of splenectomy, and leukemic transformation.
Journal ArticleDOI
Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis
Berent J. Prakken,Rodrigo Samodal,Tho Le,Francesca Giannoni,Gisella Puga Yung,John Scavulli,Diane Amox,Sarah Roord,Ismé M. de Kleer,Dustan Bonnin,Paola Lanza,Charles C. Berry,Margherita Massa,Rosario Billetta,Salvatore Albani +14 more
TL;DR: The observed change in immune reactivity to dnaJP1 was the outcome of treatment-induced emergence of T cells with a different functional phenotype, contributing to the knowledge of mechanisms and tools needed for antigen-specific immune modulation in humans, thus laying the foundation for exploitation for therapeutic purposes.
Journal ArticleDOI
Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.
F De Benedetti,Margherita Massa,Pier Franco Pignatti,Salvatore Albani,Daniela Novick,Alberto Martini +5 more
TL;DR: The large quantities of serum IL- 6 present in IL-6/sIL-6 R complexes appear to be biologically relevant in vivo, at least as far as the induction by IL-8 of acute phase protein production.